Literature DB >> 16325980

Subacute effects of the brominated flame retardants hexabromocyclododecane and tetrabromobisphenol A on hepatic cytochrome P450 levels in rats.

Silke Germer1, Aldert H Piersma, Leo van der Ven, Andreas Kamyschnikow, Yvonne Fery, Hans-Joachim Schmitz, Dieter Schrenk.   

Abstract

The brominated flame retardants tetrabromobisphenol A (TBBPA) and hexabromocyclododecane (HBCD) are found in the environment, e.g., in sediments and organisms, in food items, human blood samples and mother's milk. In this study, the effects of both compounds on rat hepatic cytochrome P450 (CYP) levels and activities were investigated. Juvenile/young male and female Wistar rats were treated orally with various doses via the feed (TBBPA) or by gavage (HBCD). After 28 days of treatment the animals were sacrificed and hepatic mRNA and microsomes were isolated. HBCD treatment led to a significant induction of CYP2B1 mRNA, CYP2B1/2B2 protein and 7-pentoxyresorufin O-depentylase (PROD) activity suggesting a phenobarbital-type of induction. Furthermore, a significant increase in CYP3A1/3A3 mRNA, CYP3A1 protein, and luciferin benzylether debenzylase (LBD) activity was found, being more pronounced in females than in males. The effect on CYP3A1/3A3 mRNA was significant in female rats at a daily dose of 3.0mg/kg body weight and above. HBCD exhibited no effects on CYP1A2 mRNA, CYP1A1/1A2 protein, or microsomal 7-ethoxyresorufin O-deethylase (EROD) activity suggesting lack of activation of the aryl hydrocarbon receptor. No significant effects on any of the parameters measured were obtained with TBBPA. Our findings suggest that oral exposure to HBCD induces drug-metabolising enzymes in rats probably via the CAR/PXR signalling pathway. Induction of CYPs and co-regulated enzymes of phase II of drug metabolism may affect homeostasis of endogenous substrates including steroid and thyroid hormones.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16325980     DOI: 10.1016/j.tox.2005.10.019

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  20 in total

1.  Brominated flame retardants, tetrabromobisphenol A and hexabromocyclododecane, activate mitogen-activated protein kinases (MAPKs) in human natural killer cells.

Authors:  Anita Cato; Lindsay Celada; Esther Caroline Kibakaya; Nadia Simmons; Margaret M Whalen
Journal:  Cell Biol Toxicol       Date:  2014-10-24       Impact factor: 6.691

2.  Exposure of Chlamys farreri to tetrabromobisphenol A: accumulation and multibiomarker responses.

Authors:  Fengxiao Hu; Luqing Pan; Meng Xiu; Qian Jin
Journal:  Environ Sci Pollut Res Int       Date:  2015-04-19       Impact factor: 4.223

3.  Antioxidant responses in clam Venerupis philippinarum exposed to environmental pollutant hexabromocyclododecane.

Authors:  Hui Zhang; Luqing Pan; Yanxia Tao
Journal:  Environ Sci Pollut Res Int       Date:  2014-03-29       Impact factor: 4.223

4.  Update of the risk assessment of hexabromocyclododecanes (HBCDDs) in food.

Authors:  Dieter Schrenk; Margherita Bignami; Laurent Bodin; James Kevin Chipman; Jesús Del Mazo; Bettina Grasl-Kraupp; Christer Hogstrand; Laurentius Ron Hoogenboom; Jean-Charles Leblanc; Carlo Stefano Nebbia; Elsa Nielsen; Evangelia Ntzani; Annette Petersen; Salomon Sand; Tanja Schwerdtle; Heather Wallace; Diane Benford; Peter Fürst; Martin Rose; Sofia Ioannidou; Marina Nikolič; Luisa Ramos Bordajandi; Christiane Vleminckx
Journal:  EFSA J       Date:  2021-03-08

5.  Effects of low-level hexabromocyclododecane (HBCD) exposure on cardiac development in zebrafish embryos.

Authors:  Meifang Wu; Zhenghong Zuo; Bowen Li; Lixing Huang; Meng Chen; Chonggang Wang
Journal:  Ecotoxicology       Date:  2013-08-01       Impact factor: 2.823

6.  Flame retardants, hexabromocyclododecane (HCBD) and tetrabromobisphenol a (TBBPA), alter secretion of tumor necrosis factor alpha (TNFα) from human immune cells.

Authors:  Sharia Yasmin; Margaret Whalen
Journal:  Arch Toxicol       Date:  2018-01-22       Impact factor: 5.153

7.  1,2,5,6,9,10-αHexabromocyclododecane (HBCD) impairs thyroid hormone-induced dendrite arborization of Purkinje cells and suppresses thyroid hormone receptor-mediated transcription.

Authors:  Kingsley Ibhazehiebo; Toshiharu Iwasaki; Noriaki Shimokawa; Noriyuki Koibuchi
Journal:  Cerebellum       Date:  2011-03       Impact factor: 3.847

8.  Hexabromocyclododecane decreases tumor-cell-binding capacity and cell-surface protein expression of human natural killer cells.

Authors:  Natasha C Hinkson; Margaret M Whalen
Journal:  J Appl Toxicol       Date:  2010-05       Impact factor: 3.446

9.  Acute effects of hexabromocyclododecane on Leydig cell cyclic nucleotide signaling and steroidogenesis in vitro.

Authors:  Svetlana Fa; Kristina Pogrmic-Majkic; Vanja Dakic; Sonja Kaisarevic; Jelena Hrubik; Nebojsa Andric; Stanko S Stojilkovic; Radmila Kovacevic
Journal:  Toxicol Lett       Date:  2013-01-21       Impact factor: 4.372

10.  The fate of β-hexabromocyclododecane in female C57BL/6 mice.

Authors:  J Michael Sanders; Gabriel A Knudsen; Linda S Birnbaum
Journal:  Toxicol Sci       Date:  2013-06-02       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.